Medical Oncology Software Market Size & Share

1. The global medical oncology software market is projected to grow from $2.70 billion in 2024 to $5.06 billion by 2032, with an 8.4% CAGR. North America dominates with a 40.74% market share, driven by rising cancer care centers and advanced technological solutions. Key trends include AI-based clinics for personalized treatment plans using genomic data, with companies like Tempus integrating genomic testing directly into oncology EHRs. The COVID-19 pandemic initially reduced sales due to limited healthcare budgets, but the market rebounded in 2021-2022 with increased patient volumes. The market segments into:  Deployment: Cloud leads due to rising healthcare IT infrastructure  Applications: Patient record management dominates, enabling streamlined coordination  End-users: Hospitals & specialty clinics hold the largest share Major players include Varian Medical Systems (Siemens Healthineers), Elekta, and Oracle (Cerner Corporation). Strategic developments focus on AI integration and clinical decision support, exemplified by Memorial Sloan Kettering's 2022 partnership with Epic Systems for integrated cancer care platforms. Report- Fortune Business Insights - Medical Oncology Software Market Size, Share | Report [2032] https://www.fortunebusinessinsights.com/medical-oncology-software-market-108933